In conjunction with its decision to discontinue a study for one of its CAR T candidates, BioNTech will close down a cell therapy facility in Gaithersburg, Maryland, and lay off 63 employees at the site, according to a June 13 WARN notice and reporting from Fierce Pharma on Thursday.